Monday, 31 August 2026European Markets

HOTELS DE PARIS Stock Was Up By 11.97% Today

Loading stream...

(vianews) - the market ended the session with hotels de paris (hdp.pa) rising 11.97% to €3.18 on monday, after two successive sessions in a row of losses. cac 40 slid 0.37% to €7,265.49, after three consecutive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

hotels de paris's last close was €2.84, 15.98% below its 52-week high of €3.38.

about hotels de paris

les hôtels de paris sa operates and manages hotels in paris. it also offers restaurant and bar services. the company operates hotels in paris, st tropez, and marrakech. les hôtels de paris sa was incorporated in 1992 and is headquartered in paris, france.

earnings per share

as for profitability, hotels de paris has a trailing twelve months eps of €-0.4.

volume

today's last reported volume for hotels de paris is 700 which is 4.94% above its average volume of 667.

volatility

hotels de paris's last week, last month's, and last quarter's current intraday variation average was a negative 1.88%, a negative 0.61%, and a positive 7.16%.

hotels de paris's highest amplitude of average volatility was 6.13% (last week), 6.98% (last month), and 7.16% (last quarter).

more news about hotels de paris (hdp.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com